Understanding Your Genetic Risk for Lafora Myoclonic Epilepsy
When epilepsy runs in your family, the uncertainty can feel overwhelming. You may worry about your children’s future or wonder about your own genetic risk. The EPM2A Gene Myoclonic Epilepsy of Lafora NGS Genetic DNA Test provides the clarity and answers you deserve. We understand the emotional weight of genetic testing, which is why we approach every case with compassion, expertise, and the highest standards of accuracy.
What This Test Reveals About Your Health
The EPM2A gene test specifically looks for mutations that cause Lafora disease, a rare inherited form of progressive myoclonic epilepsy. Using Next-Generation Sequencing (NGS) technology, we examine your DNA with exceptional precision to identify any changes in the EPM2A gene that could lead to this neurological condition. This isn’t just a test – it’s a pathway to understanding your genetic blueprint and making informed decisions about your health journey.
Is This Test Right for You or Your Family?
This test is particularly important if you or your family members experience:
- Unexplained seizures or epilepsy symptoms starting in adolescence
- Myoclonic jerks (sudden, brief muscle twitches)
- Progressive neurological decline with cognitive changes
- Family history of epilepsy or neurological disorders
- Concerns about passing genetic conditions to children
Many South African families find peace of mind through genetic testing, especially when there’s a pattern of neurological conditions across generations.
Why Early Detection Matters for Your Future
Knowing your genetic status empowers you to:
- Make informed family planning decisions with genetic counselling support
- Access appropriate medical care and monitoring if needed
- Reduce anxiety through definitive answers rather than uncertainty
- Participate in research and emerging treatment options
- Plan for the future with confidence and clarity
Early genetic insight can transform fear into actionable knowledge, giving you control over your health journey.
Understanding Your Results with Compassion
We know waiting for genetic results can be stressful. That’s why we provide:
- Clear, easy-to-understand result reports with professional explanations
- Access to genetic counselling to discuss your results and their implications
- Guidance on next steps, whether your results are positive or negative
- Support in understanding what your genetic information means for your family
- Connection to appropriate medical specialists if further care is needed
Your results come with the professional support you need to make sense of them and plan your next steps.
Transparent Pricing – No Hidden Costs
| Service | Regular Price | Special Price |
|---|---|---|
| EPM2A Gene Test | ZAR 9,350 | ZAR 6,700 |
| Genetic Counselling Session | Included at no extra cost | |
| Family Pedigree Analysis | Included at no extra cost | |
| Result Explanation | Included at no extra cost | |
Consider this investment in your health: early detection could save significant future healthcare costs and provide priceless peace of mind.
Why South Africans Trust Oracle Genomics
- Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Expert Neurology Specialisation: Tests designed and interpreted by neurological genetics specialists
- Advanced NGS Technology: Latest genetic sequencing for maximum accuracy
- 3-4 Week Turnaround: Clear timelines so you’re not left waiting unnecessarily
- Multiple Sample Options: Blood, extracted DNA, or simple blood spot on FTA card
- Comprehensive Preparation: Includes clinical history review and genetic counselling
Take the First Step Toward Genetic Clarity
Don’t let uncertainty about genetic epilepsy risks control your life. Our special pricing of ZAR 6,700 makes this crucial testing accessible to South African families. Every day you wait is another day of uncertainty – take action today for the peace of mind you deserve.
Limited Time Special: Book your EPM2A Gene test today and receive priority scheduling and extended genetic counselling support at no additional cost.
